DK3908321T3 - Farmaceutisk sammensætning - Google Patents

Farmaceutisk sammensætning Download PDF

Info

Publication number
DK3908321T3
DK3908321T3 DK20700453.2T DK20700453T DK3908321T3 DK 3908321 T3 DK3908321 T3 DK 3908321T3 DK 20700453 T DK20700453 T DK 20700453T DK 3908321 T3 DK3908321 T3 DK 3908321T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DK20700453.2T
Other languages
English (en)
Inventor
Christophe Roberge
Noriega Adolfo Lopez
Jean Manuel Cros
Juliette Serindoux
Murielle Oster
Fang Liu
Charlotte Molinier
Sylvestre Grizot
Tjasa Vrlinic
Feifei Ng
Elise Guégain
Marie-Emérentienne Cagnon
Original Assignee
Medincell S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medincell S A filed Critical Medincell S A
Application granted granted Critical
Publication of DK3908321T3 publication Critical patent/DK3908321T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK20700453.2T 2019-01-08 2020-01-08 Farmaceutisk sammensætning DK3908321T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1900258.3A GB201900258D0 (en) 2019-01-08 2019-01-08 Pharmaceutical composition
PCT/EP2020/050333 WO2020144239A1 (en) 2019-01-08 2020-01-08 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK3908321T3 true DK3908321T3 (da) 2024-01-15

Family

ID=65528088

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20700453.2T DK3908321T3 (da) 2019-01-08 2020-01-08 Farmaceutisk sammensætning

Country Status (22)

Country Link
US (1) US20220118003A1 (da)
EP (2) EP4289429A3 (da)
JP (1) JP2022517939A (da)
KR (1) KR20210113251A (da)
CN (1) CN113543775B (da)
AU (1) AU2020205438A1 (da)
BR (1) BR112021013456A2 (da)
CA (1) CA3125372A1 (da)
DK (1) DK3908321T3 (da)
EA (1) EA202191603A1 (da)
ES (1) ES2968432T3 (da)
FI (1) FI3908321T3 (da)
GB (1) GB201900258D0 (da)
HR (1) HRP20231667T1 (da)
HU (1) HUE064916T2 (da)
LT (1) LT3908321T (da)
MX (1) MX2021008248A (da)
PL (1) PL3908321T3 (da)
PT (1) PT3908321T (da)
RS (1) RS65067B1 (da)
SI (1) SI3908321T1 (da)
WO (1) WO2020144239A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112024002231A2 (pt) 2021-08-05 2024-04-30 Medincell S A Composição farmacêutica

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2016A (en) 1841-03-26 Mode of constructing fireplaces and chimney-staoks ii
FR2741628B1 (fr) 1995-11-29 1998-02-06 Centre Nat Rech Scient Nouveaux hydrogels a base de copolymeres trisequences et leur application notamment a la liberation progressive de principes actifs
US6461631B1 (en) 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
KR100416242B1 (ko) * 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
US7649023B2 (en) * 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
JP5539725B2 (ja) * 2006-11-27 2014-07-02 アクタマックス サージカル マテリアルズ リミテッド ライアビリティ カンパニー 分岐末端反応物及びそれから製造されるポリマーヒドロゲル組織接着剤
EA027046B1 (ru) 2010-12-29 2017-06-30 Мединселл Биоразлагаемая композиция для доставки лекарственных средств, способ ее получения и ее применение
CN102432852B (zh) * 2011-08-25 2013-10-16 复旦大学 一种聚乳酸基立构复合交联共聚物及其制备方法
WO2014001904A1 (en) * 2012-06-27 2014-01-03 Medincell Biodegradable drug delivery for hydrophobic compositions
JP2016522169A (ja) 2013-04-11 2016-07-28 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション 生理活性薬剤の制御された送達のための組成物
LT3377041T (lt) * 2015-11-16 2023-12-27 Medincell S.A. Farmaciškai aktyvių komponentų suskaidymo ir (arba) nukreipimo į sinovinį audinį būdas
AR113096A1 (es) 2017-07-17 2020-01-29 Medincell Mezclas de composiciones biodegradables que modulan la cinética de liberación de al menos un ingrediente activo en la administración de fármacos
CN108586775B (zh) * 2018-05-04 2019-11-12 四川大学 可用于眼内长期填充的原位交联超支化聚醚类水凝胶及其制备方法

Also Published As

Publication number Publication date
LT3908321T (lt) 2024-01-25
FI3908321T3 (fi) 2024-01-11
EP3908321B1 (en) 2023-11-15
PL3908321T3 (pl) 2024-03-25
WO2020144239A1 (en) 2020-07-16
CN113543775B (zh) 2023-11-24
PT3908321T (pt) 2024-01-15
JP2022517939A (ja) 2022-03-11
GB201900258D0 (en) 2019-02-27
HUE064916T2 (hu) 2024-04-28
CA3125372A1 (en) 2020-07-16
RS65067B1 (sr) 2024-02-29
EP4289429A3 (en) 2024-03-20
US20220118003A1 (en) 2022-04-21
EP3908321A1 (en) 2021-11-17
MX2021008248A (es) 2021-10-13
CN113543775A (zh) 2021-10-22
KR20210113251A (ko) 2021-09-15
HRP20231667T1 (hr) 2024-03-15
AU2020205438A1 (en) 2021-07-29
BR112021013456A2 (pt) 2021-09-14
SI3908321T1 (sl) 2024-03-29
EA202191603A1 (ru) 2021-10-20
ES2968432T3 (es) 2024-05-09
EP4289429A2 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
KR102281667B9 (ko) 아트로핀 약학 조성물 (atropine pharmaceutical compositions)
DK3529248T3 (da) Farmaceutiske sammensætninger
MA47516A (fr) Composition pharmaceutique
MA49837A (fr) Compositions pharmaceutiques
GB201911517D0 (en) Pharmaceutical composition
DK3672631T3 (da) Farmaceutiske sammensætninger indeholdende anti-beta-amyloid-antistoffer
DK3738452T3 (da) Fordamper
GB201807053D0 (en) Pharmaceutical composition
DK3840596T3 (da) Sammensætning
SG11202103374TA (en) Pharmaceutical composition
DK3908321T3 (da) Farmaceutisk sammensætning
DK4076404T3 (da) Farmaceutisk pyrazolsammensætning
DK3911298T3 (da) Formuleringer
SG11202110315SA (en) Pharmaceutical composition
MA49625A (fr) Compositions pharmaceutiques
DK3996688T3 (da) Farmaceutisk præparat
MA55501A (fr) Compositions otologiques
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
DK3969126T3 (da) Deodorantsammensætning
IL285728A (en) Pharmaceutical composition
MA52129A (fr) Compositions
GB201820689D0 (en) Pharmaceutical composition
DK3728220T3 (da) Farmaceutiske forbindelser
GB201912686D0 (en) Pharmaceutical composition
ES1243687Y (es) Salmorejo